Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

Citation
W. Berry et al., Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate, SEMIN ONCOL, 28(4), 2001, pp. 8-15
Citations number
22
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
28
Issue
4
Year of publication
2001
Supplement
15
Pages
8 - 15
Database
ISI
SICI code
0093-7754(200108)28:4<8:PITOSW>2.0.ZU;2-B